Stock Earnings

Question 1

What are NLS Pharmaceutics AG's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), NLS Pharmaceutics AG has a total asset of $2, Net loss of $-4

Question 2

What are the key financial ratios for NCEL?

Accepted Answer

NLS Pharmaceutics AG's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is NLS Pharmaceutics AG's revenue broken down by segment or geography?

Accepted Answer

Currently NLS Pharmaceutics AG data is not available.

Question 4

Is NLS Pharmaceutics AG profitable?

Accepted Answer

no, according to the latest financial statements, NLS Pharmaceutics AG has a net loss of $-4

Question 5

Does NLS Pharmaceutics AG have any liabilities?

Accepted Answer

no, NLS Pharmaceutics AG has liability of 0

Question 6

How many outstanding shares for NLS Pharmaceutics AG?

Accepted Answer

NLS Pharmaceutics AG has a total outstanding shares of 0.31

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	3	3	5	6	5	2
Research & Development	0	0	5	8	5	0
Operating Expenses	3	3	11	15	11	2
Other Non Operating Income (Expenses)	0	0	0	--	--	--
Pretax Income	-2	-1	-12	-16	-11	-2
Income Tax Expense	--	0	--	--	--	--
Net Income	-6	-4	-12	-16	-11	-2
Net Income Growth	0%	-67%	-25%	45%	450%	-60%
Shares Outstanding (Diluted)	0.4	0.15	0.09	19.68	11.9	11.78
Shares Change (YoY)	282%	62%	-100%	65%	1%	0%
EPS (Diluted)	-15.51	-26.28	-127.53	-0.84	-1	-0.24
EPS Growth	-75%	-79%	15,083%	-16%	317%	-48%
Free Cash Flow	-4	-4	-9	-13	-14	0
Free Cash Flow Per Share	-9.98	-25.92	-94.33	-0.66	-1.17	0
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-3	-3	-11	-15	-11	--
EBITDA Margin	0%	0%	0%	0%	0%	--
D&A For EBITDA	0	0	0	0	0	--
EBIT	-3	-3	-11	-15	-11	-2
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

NLS Pharmaceutics AG (NCEL) Price